scispace - formally typeset
D

Deborah C. Koltai

Researcher at Duke University

Publications -  21
Citations -  1118

Deborah C. Koltai is an academic researcher from Duke University. The author has contributed to research in topics: Epilepsy & Health care. The author has an hindex of 7, co-authored 17 publications receiving 670 citations. Previous affiliations of Deborah C. Koltai include University of Bergen.

Papers
More filters
Journal ArticleDOI

Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence

Jeanne E. Savage, +135 more
- 25 Jun 2018 - 
TL;DR: A large-scale genetic association study of intelligence identifies 190 new loci and implicates 939 new genes related to neurogenesis, neuron differentiation and synaptic structure, a major step forward in understanding the neurobiology of cognitive function as well as genetically related neurological and psychiatric disorders.
Posted ContentDOI

GWAS meta-analysis (N=279,930) identifies new genes and functional links to intelligence

Jeanne E. Savage, +138 more
- 06 Sep 2017 - 
TL;DR: The largest genetic association study of intelligence to date is presented, identifying 206 genomic loci and implicating 1,041 genes (963 novel) via positional mapping, expression quantitative trait locus (eQTL) mapping, chromatin interaction mapping, and gene-based association analysis.
Journal ArticleDOI

Stigma reduction interventions for epilepsy: A systematized literature review.

TL;DR: More work is needed in both developing effective stigma reduction strategies, especially in LMICs, and validating tools to measure their efficacy, as well as highlighting gaps and directions for future interventions.
Journal ArticleDOI

COVID-19-Associated Guillain-Barre Syndrome: Atypical Para-infectious Profile, Symptom Overlap, and Increased Risk of Severe Neurological Complications.

TL;DR: Inclusion of a neurological assessment during diagnosis of COVID-19 might facilitate timely identification and effective management of the GBS symptoms and improve treatment outcome, and increase the likelihood of symptom overlap.